The alpha-lipoic acid decreases urinary podocalyxin excretion in type 2 diabetics by inhibiting oxidative stress in vivo

Journal of Diabetes and its Complications

Volumn 29, Issue 1, 2015, Pages 64-67

  Lin, Haiyan ^a,b   Ye, Shandong ^a   Xu, Jiang ^a   Wang, Wei ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b Department of Internal Medicine Maanshan Maternal and Child Health Care Center   (China)

Author keywords

Alpha lipoic acid; Diabetic nephropathy; Oxidative stress; Podocalyxin; Podocyte

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ALBUMIN; ALPHA GLUCOSIDASE INHIBITOR; CREATININE; DEOXYGUANOSINE; GLUCOSE; GLUTATHIONE PEROXIDASE; GLYCOSIDASE INHIBITOR; HEMOGLOBIN A1C; INSULIN; INSULIN DERIVATIVE; MALONALDEHYDE; METFORMIN; PODOCALYXIN; SUPEROXIDE DISMUTASE; THIOCTIC ACID; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; SIALOGLYCOPROTEIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL OBSERVATION; CONTROLLED STUDY; CORRELATIONAL STUDY; CREATININE URINE LEVEL; DIABETIC PATIENT; DIAGNOSTIC TEST ACCURACY STUDY; DIET RESTRICTION; DRUG EFFICACY; ENZYME ACTIVITY; FASTING BLOOD GLUCOSE; FEMALE; GLOMERULUS; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INSULIN TREATMENT; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PODOCYTE; PREDICTIVE VALUE; SERUM; TREATMENT DURATION; TREATMENT OUTCOME; URINALYSIS; URINARY EXCRETION; ALBUMINURIA; ANALYSIS; CASE CONTROL STUDY; DIABETES MELLITUS, TYPE 2; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG EFFECTS; FOLLOW UP; METABOLISM; REFERENCE VALUE; STATISTICAL MODEL; URINE;

ADULT; ALBUMINURIA; BIOMARKERS; BLOOD GLUCOSE; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LINEAR MODELS; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; REFERENCE VALUES; SIALOGLYCOPROTEINS; SUPEROXIDE DISMUTASE; THIOCTIC ACID; TREATMENT OUTCOME;

EID: 84920519500     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2014.09.011     Document Type: Article

References (24)

1. X.H. Bao, J. Xu, and Y. Chen Alleviation of podocyte injury: The possible pathway implicated in anti-inflammation of alpha-lipoic acid in type 2 diabetics Aging Clinical and Experimental Research 2014 10.1007/s40520-014-0207-1 [Epub ahead of print]
2. S. Brähler, C. Ising, and H. Hagmann Intrinsic proinflammatory signaling in podocytes contributes to podocyte damage and prolonged proteinuria American Journal of Physiology. Renal Physiology 303 2012 F1473 F1485
3. T.S. Foster Efficacy and safety of alpha-lipoic acid supplementation in the treatment of symptomatic diabetic neuropathy The Diabetes Educator 33 2007 111 117
4. Q.M. Ge, Y. Dong, and H.M. Zhang Effects of intermittent high glucose on oxidative stress in endothelial cells Acta Diabetologica 47 2010 97 103
5. S. Ghibu, C. Richard, and C. Vergely Antioxidant properties of an endogenous thiol: Alpha-lipoic acid, useful in the prevention of cardiovascular diseases Journal of Cardiovascular Pharmacology 54 2009 391 398
6. X.M. Gu, S.S. Zhang, and J.C. Wu Efficacy and safety of high-dose α-lipoic acid in the treatment of diabetic polyneuropathy Zhonghua Yi Xue Za Zhi 90 2010 2473 2476
7. D. Gui, Y. Guo, and F. Wang Astragaloside IV, a novel antioxidant, prevents glucose-induced podocyte apoptosis in vitro and in vivo PloS One 7 2012 e39824
8. M. Hara, K. Yamagata, and Y. Tomino Urinary podocalyxin is an early marker for podocyte injury in patients with diabetes: Establishment of a highly sensitive ELISA to detect urinary podocalyxin Diabetologia 55 2012 2913 2919
9. K. Ibrahimpasic Alpha lipoic acid and glycaemic control in diabetic neuropathies at type 2 diabetes treatment Medicine Archives 67 2013 7 9
10. K. Kanno, H. Kawachi, and Y. Uchida Urinary sediment podocalyxin in children with glomerular diseases Nephron. Clinical Practice 95 2003 c91 c99
11. J. Keith Dove, Judy A. Butler, and Brett Bemer Age and gender dependent bioavailability of R- and R, S-a-lipoic acid: A pilot study Pharmacological Research 66 2012 199 206
12. K. Khazim, Y. Gorin, and R.C. Cavaglieri The antioxidant silybin prevents high glucose-induced oxidative stress and podocyte injury in vitro and in vivo American Journal of Physiology. Renal Physiology 305 2013 F691 F700
13. G. Li, Y. Li, and S. Liu Gremlin aggravates hyperglycemia-induced podocyte injury by a TGFβ/smad dependent signaling pathway Journal of Cellular Biochemistry 114 2013 2101 2113
14. K. Li, J. Wang, and X. Yin Alteration of podocyte protein expression and localization in the early stage of various hemodynamic conditions International Journal of Molecular Sciences 14 2013 5998 6011
15. X.Z. Li, H.D. Yan, and J. Wang Extract of Ginkgo biloba and alpha-lipoic acid attenuate advanced glycation end products accumulation and RAGE expression in diabetic nephropathy rats Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi 31 2011 525 531
16. D.K. Singh, P. Winocour, and K. Farrington Oxidative stress in early diabetic nephropathy: Fueling the fire Nature Reviews Endocrinology 7 2011 176 184
17. B. Siu, J. Saha, and W.E. Smoyer Reduction in podocyte density as a pathologic feature in early diabetic nephropathy in rodents: Prevention by lipoic acid treatment BMC Nephrology 15 2006 6
18. T. Takeda, W.Y. Go, and R.A. Orlando Expression of podocalyxin inhibits cell-cell adhesion and modifies junctional properties in Madin-Darby canine kidney cells Molecular Biology of the Cell 11 2000 3219 3232
19. L. Wang, Y. Tang, and W. Eisner Augmenting podocyte injury promotes advanced diabetic kidney disease in Akita mice Biochemical and Biophysical Research Communications 444 2014 622 627
20. L. Wang, C.G. Wu, and C.Q. Fang The protective effect of α-Lipoic acid on mitochondria in the kidney of diabetic rats International journal of clinical and experimental medicine 6 2013 90 97
21. E.J. Weil, K.V. Lemley, and C.C. Mason Podocyte detachment and reduced glomerular capillary endothelial fenestration promote kidney disease in type 2 diabetic nephropathy Kidney International 82 2012 1010 1017
22. Q. Yan, K. Gao, and Y. Chi NADPH oxidase-mediated upregulation of connexin43 contributes to podocyte injury Free Radical Biology and Medicine 53 2012 1286 1297
23. K. Yasuno, S. Ishihara, and R. Saito Early-onset podocyte injury and glomerular sclerosis in osborne-mendel rats Journal of Veterinary Medical Science 72 2010 1319 1327
24. X. Yi, V. Nickeleit, and L.R. James α-Lipoic acid protects diabetic apolipoprotein E-deficient mice from nephropathy Journal of Diabetes and its Complications 25 2011 193 201